Insider Trading Activity For Keryx Biopharmaceuticals (NASDAQ:KERX)
Christine A Carberry , COO of Keryx Biopharmaceuticals (NASDAQ:KERX) reportedly Sold 9,048 shares of the company’s stock at an average price of 4.87 for a total transaction amount of $44,063.76 SEC Form
Insider Trading History For Keryx Biopharmaceuticals (NASDAQ:KERX)
Analyst Ratings History For Keryx Biopharmaceuticals (NASDAQ:KERX)
- On 2/26/2016 JPMorgan Chase & Co. Downgraded rating Overweight to Neutral
- On 3/29/2016 BTIG Research Reiterated Rating Sell with a price target of $2.50
- On 8/2/2016 Brean Capital Downgraded rating Buy to Hold
- On 8/2/2016 Ladenburg Thalmann Financial Services Boost Price Target of rating Buy with a price target of $9.00 to $10.00
- On 8/2/2016 Raymond James Financial Boost Price Target of rating Outperform with a price target of $7.00 to $10.00
- On 9/8/2016 JMP Securities Reiterated Rating Outperform
- On 11/19/2016 FBR & Co Reiterated Rating Hold
Recent Trading Activity for Keryx Biopharmaceuticals (NASDAQ:KERX)
Shares of Keryx Biopharmaceuticals closed the previous trading session at 4.86 +0.00 0.00% with 4.840000152587891 shares trading hands.